|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 301 to 348 out of 348 for Vhl

Category restricted to Publication (x)

<< First    < Previous  |  Next >    Last >>
0.031s

Categories

Category: Publication
« show all
Type Details Score
Publication
12004076 | -
First Author: Min JH
Year: 2002
Journal: Science
Title: Structure of an HIF-1alpha -pVHL complex: hydroxyproline recognition in signaling.
Volume: 296
Issue: 5574
Pages: 1886-9
•
•
•
•
•
Publication
19414081 | -
First Author: Meister M
Year: 2009
Journal: Clin Radiol
Title: Radiological evaluation, management, and surveillance of renal masses in Von Hippel-Lindau disease.
Volume: 64
Issue: 6
Pages: 589-600
•
•
•
•
•
Publication
19261475 | -
First Author: Hayden MG
Year: 2009
Journal: J Clin Neurosci
Title: Von Hippel-Lindau disease in pregnancy: a brief review.
Volume: 16
Issue: 5
Pages: 611-3
•
•
•
•
•
Publication
17932373 | -
First Author: Walmsley SR
Year: 2008
Journal: Am J Respir Cell Mol Biol
Title: The HIF/VHL pathway: from oxygen sensing to innate immunity.
Volume: 38
Issue: 3
Pages: 251-5
•
•
•
•
•
Publication
17255293 | -
First Author: Kaelin WG Jr
Year: 2007
Journal: Clin Cancer Res
Title: The von Hippel-Lindau tumor suppressor protein and clear cell renal carcinoma.
Volume: 13
Issue: 2 Pt 2
Pages: 680s-684s
•
•
•
•
•
Publication
18323857 | -
First Author: Russell RC
Year: 2008
Journal: EMBO Rep
Title: NEDD8 acts as a 'molecular switch' defining the functional selectivity of VHL.
Volume: 9
Issue: 5
Pages: 486-91
•
•
•
•
•
Publication
16728571 | -
First Author: Woodward ER
Year: 2006
Journal: Endocr Relat Cancer
Title: Von Hippel-Lindau disease and endocrine tumour susceptibility.
Volume: 13
Issue: 2
Pages: 415-25
•
•
•
•
•
Publication
16531988 | -
First Author: Haase VH
Year: 2006
Journal: Kidney Int
Title: The VHL/HIF oxygen-sensing pathway and its relevance to kidney disease.
Volume: 69
Issue: 8
Pages: 1302-7
•
•
•
•
•
Publication
16869749 | -
 
First Author: Kaelin WG
Year: 2005
Journal: Cold Spring Harb Symp Quant Biol
Title: The von Hippel-Lindau tumor suppressor protein: roles in cancer and oxygen sensing.
Volume: 70
Pages: 159-66
•
•
•
•
•
Publication
23990666 | -
First Author: Desimone MC
Year: 2013
Journal: J Natl Cancer Inst
Title: Pleiotropic effects of the trichloroethylene-associated P81S VHL mutation on metabolism, apoptosis, and ATM-mediated DNA damage response.
Volume: 105
Issue: 18
Pages: 1355-64
•
•
•
•
•
Publication
14973063 | -
First Author: Zhou MI
Year: 2004
Journal: Cancer Res
Title: Tumor suppressor von Hippel-Lindau (VHL) stabilization of Jade-1 protein occurs through plant homeodomains and is VHL mutation dependent.
Volume: 64
Issue: 4
Pages: 1278-86
•
•
•
•
•
Publication
10878807 | -
First Author: Ohh M
Year: 2000
Journal: Nat Cell Biol
Title: Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein.
Volume: 2
Issue: 7
Pages: 423-7
•
•
•
•
•
Publication
22451918 | -
First Author: Delgehyr N
Year: 2012
Journal: Proc Natl Acad Sci U S A
Title: Drosophila Mgr, a Prefoldin subunit cooperating with von Hippel Lindau to regulate tubulin stability.
Volume: 109
Issue: 15
Pages: 5729-34
•
•
•
•
•
Publication
7660129 | -
First Author: Aso T
Year: 1995
Journal: Science
Title: Elongin (SIII): a multisubunit regulator of elongation by RNA polymerase II.
Volume: 269
Issue: 5229
Pages: 1439-43
•
•
•
•
•
Publication
2276737 | J:10958
First Author: Hosoe S
Year: 1990
Journal: Genomics
Title: Localization of the von Hippel-Lindau disease gene to a small region of chromosome 3.
Volume: 8
Issue: 4
Pages: 634-40
•
•
•
•
•
Publication
38690263 | J:349453
 
First Author: Bargiela D
Year: 2024
Journal: Front Immunol
Title: The factor inhibiting HIF regulates T cell differentiation and anti-tumour efficacy.
Volume: 15
Pages: 1293723
•
•
•
•
•
Publication
23054256 | J:190585
First Author: Ding M
Year: 2013
Journal: Am J Physiol Renal Physiol
Title: Regulation of hypoxia-inducible factor 2-a is essential for integrity of the glomerular barrier.
Volume: 304
Issue: 1
Pages: F120-6
•
•
•
•
•
Publication
22308027 | J:183274
First Author: Paatero I
Year: 2012
Journal: J Biol Chem
Title: Interaction with ErbB4 promotes hypoxia-inducible factor-1α signaling.
Volume: 287
Issue: 13
Pages: 9659-71
•
•
•
•
•
Publication
35045308 | J:327100
First Author: Evers SS
Year: 2022
Journal: Cell Rep
Title: Gut HIF2α signaling is increased after VSG, and gut activation of HIF2α decreases weight, improves glucose, and increases GLP-1 secretion.
Volume: 38
Issue: 3
Pages: 110270
•
•
•
•
•
Publication
24899725 | J:211627
First Author: Parsanejad M
Year: 2014
Journal: J Neurosci
Title: Regulation of the VHL/HIF-1 pathway by DJ-1.
Volume: 34
Issue: 23
Pages: 8043-50
•
•
•
•
•
Publication
1680799 | J:11487
First Author: Maher ER
Year: 1991
Journal: Genomics
Title: Mapping of the von Hippel-Lindau disease locus to a small region of chromosome 3p by genetic linkage analysis.
Volume: 10
Issue: 4
Pages: 957-60
•
•
•
•
•
Publication
10449904 | J:57300
First Author: Ishida T
Year: 1999
Journal: Cytogenet Cell Genet
Title: Structure and chromosome location of human OGG1.
Volume: 85
Issue: 3-4
Pages: 232-6
•
•
•
•
•
Publication
28528867 | J:242567
First Author: Zhang Y
Year: 2017
Journal: Cancer Cell
Title: A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations.
Volume: 31
Issue: 6
Pages: 820-832.e3
•
•
•
•
•
Publication
9630229 | J:48636
First Author: Vainberg IE
Year: 1998
Journal: Cell
Title: Prefoldin, a chaperone that delivers unfolded proteins to cytosolic chaperonin.
Volume: 93
Issue: 5
Pages: 863-73
•
•
•
•
•
Publication
12056827 | J:77242
First Author: Li Z
Year: 2002
Journal: Biochem Biophys Res Commun
Title: Identification of a deubiquitinating enzyme subfamily as substrates of the von Hippel-Lindau tumor suppressor.
Volume: 294
Issue: 3
Pages: 700-9
•
•
•
•
•
Publication
23001567 | J:191148
First Author: Foy RL
Year: 2012
Journal: Hum Mol Genet
Title: Polycystin-1 regulates the stability and ubiquitination of transcription factor Jade-1.
Volume: 21
Issue: 26
Pages: 5456-71
•
•
•
•
•
Publication
30785802 | J:292059
First Author: Wang M
Year: 2019
Journal: FASEB J
Title: High glucose-induced ubiquitination of G6PD leads to the injury of podocytes.
Volume: 33
Issue: 5
Pages: 6296-6310
•
•
•
•
•
Publication
34099651 | J:322190
First Author: Li G
Year: 2021
Journal: Nat Commun
Title: A small molecule HIF-1α stabilizer that accelerates diabetic wound healing.
Volume: 12
Issue: 1
Pages: 3363
•
•
•
•
•
Publication
29872221 | J:267404
First Author: Miess H
Year: 2018
Journal: Oncogene
Title: The glutathione redox system is essential to prevent ferroptosis caused by impaired lipid metabolism in clear cell renal cell carcinoma.
Volume: 37
Issue: 40
Pages: 5435-5450
•
•
•
•
•
Publication
39365820 | J:357549
First Author: Stransky LA
Year: 2024
Journal: Proc Natl Acad Sci U S A
Title: Toward a CRISPR-based mouse model of Vhl-deficient clear cell kidney cancer: Initial experience and lessons learned.
Volume: 121
Issue: 41
Pages: e2408549121
•
•
•
•
•
Publication
21908555 | J:177381
First Author: Fu L
Year: 2011
Journal: Cancer Res
Title: Generation of a mouse model of Von Hippel-Lindau kidney disease leading to renal cancers by expression of a constitutively active mutant of HIF1α.
Volume: 71
Issue: 21
Pages: 6848-56
•
•
•
•
•
Publication
11237528 | J:69240
First Author: Kondo K
Year: 2001
Journal: Exp Cell Res
Title: The von Hippel-Lindau tumor suppressor gene.
Volume: 264
Issue: 1
Pages: 117-25
•
•
•
•
•
Publication
11555645 | J:72777
First Author: Vaux EC
Year: 2001
Journal: J Biol Chem
Title: Selection of mutant CHO cells with constitutive activation of the HIF system and inactivation of the von Hippel-Lindau tumor suppressor.
Volume: 276
Issue: 47
Pages: 44323-30
•
•
•
•
•
Publication
11839561 | J:74502
First Author: Hiroyasu M
Year: 2002
Journal: Am J Pathol
Title: Specific allelic loss of p16 (INK4A) tumor suppressor gene after weeks of iron-mediated oxidative damage during rat renal carcinogenesis.
Volume: 160
Issue: 2
Pages: 419-24
•
•
•
•
•
Publication
10679386 | J:60798
First Author: Macleod K
Year: 2000
Journal: Curr Opin Genet Dev
Title: Tumor suppressor genes.
Volume: 10
Issue: 1
Pages: 81-93
•
•
•
•
•
Publication
2894613 | J:9069
First Author: Seizinger BR
Year: 1988
Journal: Nature
Title: Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma.
Volume: 332
Issue: 6161
Pages: 268-9
•
•
•
•
•
Publication
17344222 | J:121285
First Author: Fu J
Year: 2007
Journal: J Biol Chem
Title: EGLN3 prolyl hydroxylase regulates skeletal muscle differentiation and myogenin protein stability.
Volume: 282
Issue: 17
Pages: 12410-8
•
•
•
•
•
Publication
21746877 | J:175074
First Author: Sengupta T
Year: 2011
Journal: Mol Cell Biol
Title: Hypoxia-inducible factor 1 is activated by dysregulated cyclin E during mammary epithelial morphogenesis.
Volume: 31
Issue: 18
Pages: 3885-95
•
•
•
•
•
Publication
21625219 | J:178571
First Author: Kim DS
Year: 2011
Journal: Oncogene
Title: Cancer cells promote survival through depletion of the von Hippel-Lindau tumor suppressor by protein crosslinking.
Volume: 30
Issue: 48
Pages: 4780-90
•
•
•
•
•
Publication
23832661 | J:199228
First Author: Peña-Llopis S
Year: 2013
Journal: Cancer Res
Title: Cooperation and antagonism among cancer genes: the renal cancer paradigm.
Volume: 73
Issue: 14
Pages: 4173-9
•
•
•
•
•
Publication
25873528 | J:224950
First Author: Liao L
Year: 2015
Journal: Cancer Genet
Title: The roles of chromatin-remodelers and epigenetic modifiers in kidney cancer.
Volume: 208
Issue: 5
Pages: 206-14
•
•
•
•
•
Publication
27780863 | J:237621
First Author: Huang SC
Year: 2016
Journal: J Biol Chem
Title: Protein 4.1R Influences Myogenin Protein Stability and Skeletal Muscle Differentiation.
Volume: 291
Issue: 49
Pages: 25591-25607
•
•
•
•
•
Publication
28082722 | J:239518
First Author: Gao W
Year: 2017
Journal: Proc Natl Acad Sci U S A
Title: Inactivation of the PBRM1 tumor suppressor gene amplifies the HIF-response in VHL-/- clear cell renal carcinoma.
Volume: 114
Issue: 5
Pages: 1027-1032
•
•
•
•
•
Publication
32156779 | J:288997
First Author: Rooney N
Year: 2020
Journal: Cancer Res
Title: RUNX1 Is a Driver of Renal Cell Carcinoma Correlating with Clinical Outcome.
Volume: 80
Issue: 11
Pages: 2325-2339
•
•
•
•
•
Publication
27608954 | J:301833
 
First Author: Lu J
Year: 2016
Journal: Brain Res
Title: Knockout of programmed cell death 5 (PDCD5) gene attenuates neuron injury after middle cerebral artery occlusion in mice.
Volume: 1650
Pages: 152-161
•
•
•
•
•
Publication
31185486 | J:356806
First Author: Radford BN
Year: 2020
Journal: Pediatr Res
Title: Evidence of increased hypoxia signaling in fetal liver from maternal nutrient restriction in mice.
Volume: 87
Issue: 3
Pages: 450-455
•
•
•
•
•
Publication
11739384 | J:74628
First Author: Li Z
Year: 2002
Journal: J Biol Chem
Title: Ubiquitination of a novel deubiquitinating enzyme requires direct binding to von Hippel-Lindau tumor suppressor protein.
Volume: 277
Issue: 7
Pages: 4656-62
•
•
•
•
•
Publication
11507080 | J:70901
First Author: Gruys ME
Year: 2001
Journal: Cancer Res
Title: Induction of transplantable mouse renal cell cancers by streptozotocin: in vivo growth, metastases, and angiogenic phenotype.
Volume: 61
Issue: 16
Pages: 6255-63
•
•
•
•
•




MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Copyright © 2017 by The Jackson Laboratory. All Rights Reserved

© 2002 - 2017 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom